| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |